Deals

Fierce Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.

Angus Liu Jan 15, 2026 10:42am

A ballpoint pen rests on top of a stack of documents ready for signing

Alfasigma pens €125M deal for injectable form of HSV treatment

Jan 15, 2026 6:45am

JPM26: All of the meetings, none of the megadeals

Jan 15, 2026 4:30am

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Charles River inks $510M deal to bring primate supply in-house

Jan 14, 2026 10:45am

Pretzel emerges as winner from rise and fall of Rome

Jan 13, 2026 9:55am

Fierce Pharma

Bristol Myers CEO pledges to 'cast a broad net' in dealmaking

Jan 12, 2026 4:28pm